je.st
news
Aeterna Zentaris: Final Data for Phase 1 Portion of Ongoing Phase 1/2 ...
2014-12-29 14:32:32| Logistics - Topix.net
The article outlines data previously disclosed in at the American Society of Clinical Oncology's Annual Meeting, which demonstrated the compound's safety profile and promising anti-tumor activity in heavily pre-treated men with castration- and taxane-resistant prostate cancer. These results led to the current investigator-driven Phase 2 portion in this same indication under the supervision of lead investigator, Norris Comprehensive Cancer Center.
Tags: data
final
phase
portion
Category:Transportation and Logistics